Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. (2018)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ejhf.1076
PubMed Identifier: 29226610
Publication URI: http://europepmc.org/abstract/MED/29226610
Type: Journal Article/Review
Volume: 20
Parent Publication: European journal of heart failure
Issue: 4
ISSN: 1388-9842